Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 30, 2013
Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry
Roberto Passera, Simona Pollichieni, Lucia Brunello, et al.
Transplantation and Cellular Therapy
|
January 27, 2025
Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE Study
Federico Stella, Martina Pennisi, Annalisa Chiappella, et al.
Transplantation and Cellular Therapy
|
February 25, 2026
Systemic inflammation and CAR-T specific toxicities as major drivers of non-relapse mortality: analysis from the Italian prospective observational CART-SIE Study
Angelica Barone, Federico Stella, Silva Ljevar, et al.
Blood Advances
|
August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Bone Marrow Transplantation
|
September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Leukemia & Lymphoma
|
January 15, 2025
Assessment of frailty and comorbidities in cellular therapies patients in Italy: results of the GITMO Elderly-Survey (GITMO ELD-Survey)
Michele Malagola, Luca Castagna, Mirko Farina, et al.
Hemasphere
|
June 8, 2026
Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study
Nicola Polverelli, Annalisa Chiappella, Cristiana Carniti, et al.
Bone Marrow Transplantation
|
April 13, 2022
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01
Francesca Bonifazi, Chiara Pavoni, Jacopo Peccatori, et al.
American Journal of Hematology
|
November 26, 2025
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study
Nicola Polverelli, Caterina Zerbi, Maria Grazia Benevento, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 30, 2013
Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry
Roberto Passera, Simona Pollichieni, Lucia Brunello, et al.
Transplantation and Cellular Therapy
|
January 27, 2025
Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE Study
Federico Stella, Martina Pennisi, Annalisa Chiappella, et al.
Transplantation and Cellular Therapy
|
February 25, 2026
Systemic inflammation and CAR-T specific toxicities as major drivers of non-relapse mortality: analysis from the Italian prospective observational CART-SIE Study
Angelica Barone, Federico Stella, Silva Ljevar, et al.
Blood Advances
|
August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Bone Marrow Transplantation
|
September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Leukemia & Lymphoma
|
January 15, 2025
Assessment of frailty and comorbidities in cellular therapies patients in Italy: results of the GITMO Elderly-Survey (GITMO ELD-Survey)
Michele Malagola, Luca Castagna, Mirko Farina, et al.
Hemasphere
|
June 8, 2026
Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study
Nicola Polverelli, Annalisa Chiappella, Cristiana Carniti, et al.
Bone Marrow Transplantation
|
April 13, 2022
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01
Francesca Bonifazi, Chiara Pavoni, Jacopo Peccatori, et al.
American Journal of Hematology
|
November 26, 2025
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study
Nicola Polverelli, Caterina Zerbi, Maria Grazia Benevento, et al.
Page
of 6